Skip to main content
Caplight Logo









OmniVis

OmniVis

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.omnivistech.com/

Last Round

Accelerator

Feb 1, 2023

Total Funding Raised

$1.47M

Company Overview

OmniVis is a biotechnology company that develops rapid, smartphone-enabled diagnostic devices for detecting pathogens in water, food, and clinical samples.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment, Environmental Monitoring

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

pathogen detectionpoint-of-care diagnosticsfield diagnosticsrapid testingsmartphone diagnosticslab-on-a-chipwater quality testingdisease surveillancemolecular diagnosticsLAMP assayoutbreak monitoringbiotech hardwareportable labrazor-and-blade modelfood safety testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OmniVis Comparables

Compare OmniVis with similar companies based on industry and business-model similarity.

OmniVis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biomeme
84%
ProtonDx
81%
Kraken Sense
78%

OmniVis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 1, 2023
SeedMar 15, 2022
GrantJul 1, 2020
GrantApr 15, 2020
GrantJul 1, 2018

OmniVis Investors

Notable investors and investment history

OmniVis Filings

Explore SEC and related filing metadata, where available.

OmniVis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OmniVis's valuation, stock price, and market status.

Is OmniVis a public or private company?

OmniVis is a private company.

What is the current stock price of OmniVis?

OmniVis is a private company with no public stock price. Caplight tracks OmniVis's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is OmniVis worth (valuation)?

Valuation information for OmniVis is not publicly available.

Can I buy OmniVis stock?

OmniVis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OmniVis's last funding round?

OmniVis's most recent funding round was Accelerator on February 1, 2023.

Who are the main investors in OmniVis?

Key investors in OmniVis include Indiana Economic Development Corporation, Purdue Ag-Celerator, Halcyon Venture Partners, National Science Foundation.

Will OmniVis IPO soon?

No public IPO plans have been announced for OmniVis.

How can I track OmniVis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OmniVis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range1
Year Founded2017
Last FundingFeb 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?